| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1019114623 |
| P356 | DOI | 10.1007/S11262-007-0116-X |
| P698 | PubMed publication ID | 17546492 |
| P2093 | author name string | Lars Rymo | |
| Weiwen Yang | |||
| Lars Palmqvist | |||
| Ann Jansson | |||
| Pegah Johansson | |||
| Anna Sjöblom-Hallén | |||
| P2860 | cites work | CIR, a corepressor linking the DNA binding factor CBF1 to the histone deacetylase complex | Q22008610 |
| Cardiac malformations, adrenal agenesis, neural crest defects and exencephaly in mice lacking Cited2, a new Tfap2 co-activator | Q24291867 | ||
| The Epstein-Barr Virus Nuclear Protein 2 Acidic Domain Forms a Complex with a Novel Cellular Coactivator That Can Interact with TFIIE | Q24329182 | ||
| A role for SKIP in EBNA2 activation of CBF1-repressed promoters | Q24524363 | ||
| The 62- and 80-kDa subunits of transcription factor IIH mediate the interaction with Epstein-Barr virus nuclear protein 2 | Q24564767 | ||
| A histone deacetylase corepressor complex regulates the Notch signal transduction pathway | Q24598533 | ||
| Epstein-Barr virus nuclear protein 2 (EBNA2) binds to a component of the human SNF-SWI complex, hSNF5/Ini1 | Q24681418 | ||
| CBP/p300 in cell growth, transformation, and development | Q28140313 | ||
| Regulatory roles of AP-2 transcription factors in vertebrate development, apoptosis and cell-cycle control | Q28141560 | ||
| Human CREB-binding protein/p300-interacting transactivator with ED-rich tail (CITED) 4, a new member of the CITED family, functions as a co-activator for transcription factor AP-2 | Q28211366 | ||
| Histone deacetylases associated with the mSin3 corepressor mediate mad transcriptional repression | Q28238089 | ||
| TRANSFAC: an integrated system for gene expression regulation | Q29614502 | ||
| Human hepatocellular carcinoma cell lines secrete the major plasma proteins and hepatitis B surface antigen | Q29617963 | ||
| Silencing of the Epstein-Barr virus latent membrane protein 1 gene by the Max-Mad1-mSin3A modulator of chromatin structure | Q33643991 | ||
| Epstein-Barr virus-encoded nuclear antigen 2 activates the viral latent membrane protein promoter by modulating the activity of a negative regulatory element | Q33810690 | ||
| An Epstein-Barr virus that expresses only the first 231 LMP1 amino acids efficiently initiates primary B-lymphocyte growth transformation | Q33825713 | ||
| Epstein-Barr virus-mediated B-cell proliferation is dependent upon latent membrane protein 1, which simulates an activated CD40 receptor | Q33888498 | ||
| Cloning and expression of AP-2, a cell-type-specific transcription factor that activates inducible enhancer elements | Q34164797 | ||
| Morphological and virological investigations on cultured Burkitt tumor lymphoblasts (strain Raji). | Q34205569 | ||
| Epstein-Barr virus nuclear protein 2 is a key determinant of lymphocyte transformation | Q34324039 | ||
| Stable replication of plasmids derived from Epstein-Barr virus in various mammalian cells | Q34564031 | ||
| Release of infectious Epstein-Barr virus by transformed marmoset leukocytes | Q35093948 | ||
| Epstein-Barr virus nuclear protein 2 transactivation of the latent membrane protein 1 promoter is mediated by J kappa and PU.1. | Q35829475 | ||
| The Epstein-Barr virus nuclear protein 2 acidic domain can interact with TFIIB, TAF40, and RPA70 but not with TATA-binding protein. | Q35830605 | ||
| The Epstein-Barr virus 3.5-kilobase latent membrane protein 1 mRNA initiates from a TATA-Less promoter within the first terminal repeat | Q35842451 | ||
| Epstein-Barr virus latent membrane protein 1 is essential for B-lymphocyte growth transformation | Q36575274 | ||
| Epstein-Barr virus nuclear proteins EBNA-3A and EBNA-3C are essential for B-lymphocyte growth transformation. | Q36686055 | ||
| The Epstein-Barr virus nuclear protein encoded by the leader of the EBNA RNAs is important in B-lymphocyte transformation | Q36828608 | ||
| Mitosis-specific hyperphosphorylation of Epstein-Barr virus nuclear antigen 2 suppresses its function | Q37009375 | ||
| Epstein-Barr virus nuclear protein 2 interacts with p300, CBP, and PCAF histone acetyltransferases in activation of the LMP1 promoter | Q37156071 | ||
| B-cell proliferation and induction of early G1-regulating proteins by Epstein-Barr virus mutants conditional for EBNA2. | Q37693393 | ||
| Epstein-Barr virus nuclear antigen 2-estrogen receptor fusion proteins transactivate viral and cellular genes and interact with RBP-J kappa in a conditional fashion. | Q38287860 | ||
| PU box-binding transcription factors and a POU domain protein cooperate in the Epstein--Barr virus (EBV) nuclear antigen 2-induced transactivation of the EBV latent membrane protein 1 promoter | Q38289794 | ||
| The Spi-1/PU.1 and Spi-B ets family transcription factors and the recombination signal binding protein RBP-J kappa interact with an Epstein-Barr virus nuclear antigen 2 responsive cis-element. | Q38301679 | ||
| An ATF/CRE element mediates both EBNA2-dependent and EBNA2-independent activation of the Epstein-Barr virus LMP1 gene promoter | Q39642344 | ||
| Differential hyperacetylation of histones H3 and H4 upon promoter-specific recruitment of EBNA2 in Epstein-Barr virus chromatin. | Q39776571 | ||
| An EBV-Genome-Negative Cell Line Established from an American Burkitt Lymphoma; Receptor Characteristics. EBV Infectibility and Permanent Conversion into EBV-Positive Sublines by <i>in vitro</i> Infection | Q40001995 | ||
| Establishment in continuous culture of a new type of lymphocyte from a “burkitt-like” malignant lymphoma (line d.g.-75) | Q40039870 | ||
| RBP-J kappa repression activity is mediated by a co-repressor and antagonized by the Epstein-Barr virus transcription factor EBNA2. | Q40397055 | ||
| The 5' flanking region of the gene for the Epstein-Barr virus-encoded nuclear antigen 2 contains a cell type specific cis-acting regulatory element that activates transcription in transfected B-cells | Q40555242 | ||
| Domains of the Epstein--Barr virus nuclear antigen 2 (EBNA2) involved in the transactivation of the latent membrane protein 1 and the EBNA Cp promoters | Q41277135 | ||
| Cell phenotype-dependent control of Epstein-Barr virus latent membrane protein 1 gene regulatory sequences | Q41543823 | ||
| Morphological transformation of human keratinocytes expressing the LMP gene of Epstein Barr virus | Q41733704 | ||
| Transformation of Balb 3T3 cells by the BNLF-1 gene of Epstein-Barr virus | Q41976287 | ||
| The role of methylation in the phenotype-dependent modulation of Epstein-Barr nuclear antigen 2 and latent membrane protein genes in cells latently infected with Epstein-Barr virus | Q42813897 | ||
| Genetic analysis of immortalizing functions of Epstein-Barr virus in human B lymphocytes | Q43679392 | ||
| A family of AP-2 proteins regulates c-erbB-2 expression in mammary carcinoma | Q45345481 | ||
| Sensitivity of Epstein-Barr virus (EBV) producer and non-producer human lymphoblastoid cell lines to superinfection with EB-virus | Q45826919 | ||
| Identification of sequences in Epstein-Barr virus DNA required for the expression of the second Epstein-Barr virus-determined nuclear antigen in COS-1 cells | Q45842631 | ||
| An EBV membrane protein expressed in immortalized lymphocytes transforms established rodent cells. | Q53541156 | ||
| P433 | issue | 2 | |
| P921 | main subject | Epstein–Barr virus | Q6900 |
| P304 | page(s) | 203-214 | |
| P577 | publication date | 2007-06-02 | |
| P1433 | published in | Virus Genes | Q15749213 |
| P1476 | title | Role of a consensus AP-2 regulatory sequence within the Epstein-Barr virus LMP1 promoter in EBNA2 mediated transactivation | |
| P478 | volume | 35 |
| Q34658852 | Burkitt's lymphoma: the Rosetta Stone deciphering Epstein-Barr virus biology. |
| Q33998709 | C-terminal region of EBNA-2 determines the superior transforming ability of type 1 Epstein-Barr virus by enhanced gene regulation of LMP-1 and CXCR7. |
| Q45323690 | Characterization of a Suppressive Cis-acting Element in the Epstein-Barr Virus LMP1 Promoter. |
| Q39982347 | Differential gene regulation by Epstein-Barr virus type 1 and type 2 EBNA2. |
| Q36736410 | Induction of Epstein-Barr Virus Oncoprotein LMP1 by Transcription Factors AP-2 and Early B Cell Factor |
| Q38140679 | Mutations in components of antiviral or microbial defense as a basis for breast cancer. |
| Q38358818 | Nuclear factor-kappaB binds to the Epstein-Barr Virus LMP1 promoter and upregulates its expression |
| Q39874197 | The LMP1 promoter can be transactivated directly by NF-kappaB. |
| Q39755299 | The p38 signaling pathway upregulates expression of the Epstein-Barr virus LMP1 oncogene |
Search more.